Science and technology of bioadhesive-based targeted oral delivery systems. Pharma Technol 2008 Nov;32(11):100-121.
Characterisation of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol 1998 Jan;25(1):74-82.
Local drug delivery for oral mucosal diseases challenges and opportunities. Oral Dis 2011 Apr;17(1):73-82.
Recent patents on oral combination drug delivery and formulations. Recent Pat Drug Deliv Formul 2011 Jan;5(1):52-60.
Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target 2007 Jul;15(6):417-427.
Oral mucosal drug delivery - an adjunct to the current therapeutic strategies in the dental management of oral diseases: review. Oral Health Dent Manag 2014 Dec;13(4):1034-1040.
A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study. Eur J Pharm Biopharm 2010 Nov;76(3):437-442.
Cyclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: A double-blind, randomized controlled trial. Br J Dermatol 2006 Jan;154(1):139-145.
Tacrolimus mouthwash as second-line treatment for erosive oral lichen planus. Ann Dermatol Venereol 2010 Oct;137(10):648-649.
Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncol 1997 Jan;33(1):47-54.
Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro. Pharmacol Res 1999 Oct;16(10):1557-1563.
Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release. J Eur Acad Dermatol Venereol 2000 Nov;14(6):473-478.
Randomized, double-blind, placebo controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res 2004 Mar 1;10(5):1565-1573.
Clinical response to photodynamic therapy in premalignant lesions and advanced head and neck carcinomas. Otolaryngol Pol 2003 Oct;57(4):501-504.
Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharmacol Res 2011 Jul;27(7):1224-1236.
An evaluation on the efficacy and safety of amlexanox oral adhesive tablets in the treatment of recurrent minor aphthous ulceration in a Chinese cohort: a randomized, double-blind, vehicle-controlled, unparallel multicenter clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 Oct;102(4):475-481.
The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behcet's disease. J Eur Acad Dermatol Venereol 2008 May;22(5):590-595.
Intraoral stimulation of salivary secretion with the cholinesterase inhibitor physostigmine as a mouth spray: a pilot study in healthy volunteers. Arch Oral Biol 2007 Nov;52(11):1097-1101.
Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 Mar;103(Suppl):1-15.
Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz Dent J 2001;12(3):209-213.
Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial. J Periodontol 2008 May;79(5):836-844.
A preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis. Sci Pharm 2011 Mar;79(1):197-212.
Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004 Mar 24;95(3):521-533.
Oral candidiasis: a review. Int J Pharm Sci 2010;2(3):36-41.
